Scomnet in the spotlight after news of FDA approval


This combination of images provided by Edwards Lifesciences shows the Sapien 3 heart valve expanded, left, and crimped for insertion. AP filepic

PETALING JAYA: Shares of medical cable company Supercomnet Technologies Bhd (Scomnet) have been seeing some interest following news that its largest client, California-based Edwards Lifesciences Corp, has received approval for its heart valve systems from the US Food and Drug Administration (FDA) on Aug 16.

Edwards Lifesciences’ share price hit a record high of US$223.95 on Aug 19.

The Star Christmas Special Promo: Save 35% OFF Yearly. T&C applies.

Monthly Plan

RM 13.90/month

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Scomnet , EdwardLifesciences , FDA , approved , valve system ,

Next In Business News

Philippine stocks set for recovery
Beauty lovers turn to TikTok and Amazon
Pricey beans�brew consumer shift
Guiding rural Thais to prosperity
Asia rides the dollar dip
EM optimism after stellar year
Trump travel ban adds to Caribbean woes
Bursa’s quiet year sets stage for comeback
Bull charges cautiously
Indonesia treads with care

Others Also Read